Effects of 17β-estradiol on the expression of IL-6, IL-11 and NF-κB in human MG-63 osteoblast-like cell line

Wang Yunlin , Liao Eyuan , Xiang Guangda , Dai Ruchun , Xiao Xinhua , Luo Xianghang

Current Medical Science ›› 2006, Vol. 26 ›› Issue (16) : 53 -58.

PDF
Current Medical Science ›› 2006, Vol. 26 ›› Issue (16) : 53 -58. DOI: 10.1007/BF02828038
Article

Effects of 17β-estradiol on the expression of IL-6, IL-11 and NF-κB in human MG-63 osteoblast-like cell line

Author information +
History +
PDF

Abstract

In order to characterize the effects of 17β estradiol (17β-E2) on the expression of IL-6, IL 11 and NF-κB in the human MG 63 osteoblast like cell line, the expression of IL-6 was detected by RT-PCR. Northern blot and Western blot. The expression of IL-11 was determined by RT-PCR, and NF-κB by Western blot. The results showed that 17β-E2 down-regulated the expression of IL 6 mRNA and protein. IL 11 mRNA and NF κB protein in MG-63 cells. It was suggested that the expression of NF-κB, IL-6 and IL-11 in MG 63 cells could be suppressed by 17β-E2, and this might lend support to estrogen replacement therapy in postmenopausal women.

Keywords

IL-6 / IL-11 / NF κB / MG-63

Cite this article

Download citation ▾
Wang Yunlin, Liao Eyuan, Xiang Guangda, Dai Ruchun, Xiao Xinhua, Luo Xianghang. Effects of 17β-estradiol on the expression of IL-6, IL-11 and NF-κB in human MG-63 osteoblast-like cell line. Current Medical Science, 2006, 26(16): 53-58 DOI:10.1007/BF02828038

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

LindsayR, HartD M, AitkenJ M, et al.. Longterm prevention of postmenopausal osteoporosis by estrogen: evidence for an increased bone mass after delayed onset of estrogen treatment. Lancet, 1976, 1: 1038-1041

[2]

BarzelU S. Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review. Am J Med, 1988, 85: 847-850

[3]

EriksenE F, ColvardD S, BergN J, et al.. Evidence of estrogen receptors in normal human osteoblast-like cells. Science (Wash. DC), 1988, 241: 84-86

[4]

BlackK, GarrettI R, MundyG R. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology, 1991, 128: 2657-2659

[5]

BismarH, DielI, ZieglerR, et al.. Increased cytokine secretion by human bone marrow cells, after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab, 1995, 80: 3351-3355

[6]

LinS C, YamateT, TaguchiY, et al.. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest, 1997, 100: 1980-1990

[7]

KokaS, PetroT M, ReinhardtR A. Estrogen inhibits interleukin-1beta-induced interleukin-6 production by human osteoblast-like cells. J Interferon Cytokine Res, 1998, 18: 479-483

[8]

MasiukiewiczU S, MitnickM, GreyA B, et al.. Estrogen modulates parathyroid hormone-induced interleukin-6 productionin vivo andin vitro. Endocrinology, 2000, 141: 2526-2531

[9]

HofbauerL C, TenR M, KhoslaS. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. J Bone Mineral Res, 1999, 14: 1330-1337

[10]

SumbrookJ, FritschE F, ManiatisT. Molecular cloning laboratory manual, 19892nd ed.Wuhan, Cold Spring Harbor laboratory Press: 363-371

[11]

SumbrookJ, FritschE F, ManiatisT. Molecular cloning laboratory manual, 19892nd ed.Wuhan, Cold Spring Harbor laboratory Press: 888-897

[12]

QuQ, HarkonenP L, MonkkonenJ, et al.. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and functionin vitro. Bone, 1999, 25: 211-215

[13]

DovioA, SartoriM L, MaseraR G, et al.. Inhibitory effect of physiological, concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression. Cytokine, 2001, 15: 47-52

[14]

WatersK M, RickardD J, RiggsB L, et al.. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J Cell Biochem, 2001, 83: 448-462

[15]

O'BrienC A, ManolagasS C. Isolation and characterization of the human gp130 promoter regulation by STATS. J Biol Chem, 1997, 272: 15003-15010

[16]

YamamotoT, MatsudaT, JunichoA, et al.. Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Lett, 2000, 486: 143-148

[17]

KellerE T, ZhangJ, YaoZ, et al.. The impact of chronic estrogen deprivation on immunologic parameters in the ovariectomized rhesus monkey (Macaca mulatta) model of menopause. J Reprod Immunol, 2001, 50: 41-55

[18]

KassemM, HarrisS A, SpelsbergT C, et al.. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res, 1996, 11: 193-199

[19]

GhoshS, MayM J, KoppE B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 1998, 16: 225-260

[20]

ShaughnessyS G, WaltonK J, DeschampsP, et al.. Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice. Cytokine, 2000, 20: 78-85

[21]

RomasE, UdagawaN, ZhouH, et al.. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med, 1996, 183: 2581-2591

AI Summary AI Mindmap
PDF

112

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/